Michael Rich
Overview
Explore the profile of Michael Rich including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
84
Citations
1034
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Khan U, Rich M, Franke M, Lachenal N, Ahmed S, Bekele A, et al.
Clin Infect Dis
. 2024 Dec;
PMID: 39658125
Background: The 2022 WHO guidelines on multi-drug/rifampicin resistant tuberculosis (MDR/RR-TB) recommend six months of bedaquiline (Bdq) in the all-oral 9-month shorter regimen and six months or longer for Bdq and...
2.
Lienhardt C, Dooley K, Nahid P, Wells C, Ryckman T, Kendall E, et al.
Bull World Health Organ
. 2024 Jul;
102(8):600-607.
PMID: 39070602
Simpler, shorter, safer and more effective treatments for tuberculosis that are easily accessible to all people with tuberculosis are desperately needed. In 2016, the World Health Organization (WHO) developed target...
3.
Korotych O, Achar J, Gurbanova E, Hovhannesyan A, Lomtadze N, Ciobanu A, et al.
Lancet Infect Dis
. 2024 Jun;
24(10):1151-1161.
PMID: 38880112
Background: In 2020, WHO guidelines prioritised the use of a standard fully oral short treatment regimen (STR) consisting of bedaquiline, levofloxacin or moxifloxacin, ethionamide, ethambutol, high-dose isoniazid, pyrazinamide, and clofazimine...
4.
Cekic S, Bediou B, Achab S, Rich M, Green C, Bavelier D
Compr Psychiatry
. 2024 May;
133:152500.
PMID: 38761770
Background: Recognizing the crucial importance of understanding the impact of video games on health in today's gaming-dominated world, our study aimed to investigate the relationship between gaming time and Internet...
5.
Tomczak K, Worhach J, Rich M, Swearingen Ludolph O, Eppling S, Sideridis G, et al.
Brain Behav
. 2024 Mar;
14(3):e3451.
PMID: 38468457
Introduction: During the COVID-19 pandemic, an influx of adolescents presented worldwide with acute onset of functional tic-like behaviors (FTLBs). Our goal was to evaluate psychosocial factors around onset, to elucidate...
6.
Romer D, Bushman B, Rich M
Pediatr Clin North Am
. 2023 Oct;
70(6):1217-1224.
PMID: 37865441
Firearm violence is now the leading cause of youth fatalities in the United States. This article outlines the various ways that entertainment media glorify the use of firearms and how...
7.
Sauer S, Mitnick C, Khan U, Hewison C, Bastard M, Holtzman D, et al.
Clin Infect Dis
. 2023 Sep;
78(1):164-171.
PMID: 37773767
Background: Quantification of recurrence risk following successful treatment is crucial to evaluating regimens for multidrug- or rifampicin-resistant (MDR/RR) tuberculosis (TB). However, such analyses are complicated when some patients die or...
8.
Sinclair-McBride K, Rich M
Lancet Child Adolesc Health
. 2023 Aug;
7(10):673-675.
PMID: 37567198
No abstract available.
9.
Sauer S, Mitnick C, Khan U, Hewison C, Bastard M, Holtzman D, et al.
medRxiv
. 2023 Jul;
PMID: 37398252
Background: Quantification of recurrence risk following successful treatment is crucial to evaluating regimens for multidrug- or rifampicin-resistant (MDR/RR) tuberculosis (TB). However, such analyses are complicated when some patients die or...
10.
Rodriguez C, Lodi S, Horsburgh C, Mitnick C, Bastard M, Huerga H, et al.
PLOS Glob Public Health
. 2023 Apr;
3(4):e0000818.
PMID: 37115740
Clarity about the role of delamanid in longer regimens for multidrug-resistant TB is needed after discordant Phase IIb and Phase III randomized controlled trial results. The Phase IIb trial found...